TVCMALL
12.3.2023 08:16:39 CET | Business Wire | Pressemeddelelse
Nylig blev Mobile World Congress (MWC) 2023 afholdt i Barcelona, og det var en stor succes. Mere end 88 000 deltagere og 2400+ udstillere deltog i denne begivenhed, herunder mange leverandører af mobiltelefontilbehør og grossister. Som Europas førende one-stop-shop for mobiltilbehør og engros/integreret forsyningskædeserviceplatform, TVCMALL deltaget også i dette digitale/mobile arrangement. TVCMALL, der er baseret i Shenzhen, Kina, som er verdens elektroniske center, tilbyder kunder en B2B mobiltilbehør engros-, sourcing- og tilpasningsløsning. Forskellige klassiske mobiltelefoncovers med læderfinish, opladere med multifunktioner og Amorus bærbare karaokehøjtalere fra TVCMALL fik stor ros af de fremmødte.
Der er multimedier i denne pressemeddelelse. Se hele meddelelsen her: https://www.businesswire.com/news/home/20230307005694/da/
TVCMALL brings one-stop wholesale solution to MWC 2023 (Photo: Business Wire)
MWC er en af verdens vigtigste telekommunikations- og teknologimesser. I løbet af de sidste 4 dage er aspekter som den seneste trend inden for mobilteknologi inklusive intelligent udstyr, 5G-netværk, AI og digitalisering blevet introduceret og delt med resten af verden.
Under showet mødte TVCMALL mange gamle kunder og mange nye venner. Mange af dem er som følger:
- Top forhandlere og distributører af mobiltelefontilbehør online
- B2C platform sælgere, Dropshippere
- Fysiske butikker, supermarkedssælgere, teleselskaber
- Gave-Tilpasningskunder (især for myndigheder, virksomheder, skoler og andre offentlige ydelser)
- OEM & ODM & OBM kunder
- Detail & Mobiltelefon værksteder
Mange kunder har samarbejdet med TVCMALL i over ti år siden etableringen i 2008, og de er vokset og udviklet sig hurtigt med TVCMALL. De udtrykte deres store påskønnelse og store taknemmelighed til TVCMALL for at levere en one-stop shop til engros, sourcing, tilpassede tjenester og andre forsyningskædetjenester.
Hvorfor de vælger TVCMALL som énuundgåelig og vigtig langsigtet partner? Fordi TVCMALL tilbyder et komplet produktkatalog med mere end 600.000 SKU'er online, og hver uge opdateres 6.000 nye produkter. Engros-processen, marketingsupport og kundeservice er effektive. TVCMALL har gode intentioner om at vokse sammen med sine kunder.
TVCMALLs omfattende anskaffelsesomkostninger er relativt lave, servicekonsistens og stabilitet er meget stærk. Derfor foretrækker mange kunder one-stop-tjenesteudbydere som TVCMALL.
Under MWC har TVCMALL etableretgod kontakt med nogle fremragende produktleverandører og e-handelstjenesteudbydere (af mobile, 3C elektroniske enheder og tilbehør).
Ii den nærmeste fremtid, med kontinuerlig TVCMALL brand og platform opgradering, vil TVCMALL styrke sit mål, "At hjælpe iværksættere med at realisere deres drømme om at lancere og opretholde en succesfuld detailforretning", og vil overholde sin forretningsdriftsfilosofi "Together we thrive". Med hensyn til specifikke strategier vil TVCMALL følge de 4 følgende anvisninger:
- Platform branding —Betjen TVCMALL-platformen som et fremtidigt århundrede gammelt brand
- Produktisering af tjenesterne - alle tjenester fra TVCMALL sammen med ideen om produktisering.
- ProduktDyb pløjning — For at være den bedste skal du trives.
- Lokalisering af TVCMALL-tjenesten — Gå globalt og lokalisere: Start lokalt marketing- og serviceteam, dybdegående forståelse og effektiv service.
TVCMALL vil se dig igen i Barcelona 2024!
For at se dette indhold fra cts.businesswire.com, så skal du give din accept på toppen af denne side.
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20230307005694/da/
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum